Rewriting the story
of human health — 

one cell at a time

Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells

Cell identity coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.

bit.bio–venn_diagram–V16-08 bit.bio–venn_diagram–V16-07

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

ioCells™

Precision reprogrammed human iPSC-derived cells for research and drug discovery.

iocells_vial_radial_0

Latest news

bit.bio featured on Sky News News
bit.bio featured on Sky News 14.03.2023
Published by Sky News
Read now
Silicon Valley Bank statement Press Release
Silicon Valley Bank statement 12.03.2023
Published by bit.bio
Read now
Solving the cell therapy access problem – by reprogramming human cells News
Solving the cell therapy access problem – by reprogramming human cells 10.03.2023
Published by Technology Dispatch
Read now
bit.bio partners with Automata on key aspect of human cell production Press Release
bit.bio partners with Automata on key aspect of human cell production 26.01.2023
Published by Automata
Read now